Chronic Obstructive Pulmonary Disease (COPD)

Novatrials is seeking volunteers with diagnosed COPD to join a clinical study of a potential new treatment. We are investigating a potential new inhaled medication that directly targets lung tissue. …

CONDITION: Respiratory

GENDER: Both males and females

AGE GROUP:?40?to 80 years

TRIAL STATUS:?Recruiting

Atherosclerotic Cardiovascular Disease

Novatrials is seeking volunteers who have been previously diagnosed with ASCVD to join a clinical study of a potential new oral treatment that may help reduce atherosclerotic plaque. Eligibility Requirements …

CONDITION: Cardiovascular

GENDER: Both males and females

AGE GROUP:?18?to 75 years

TRIAL STATUS:?Recruiting

Type 2 Diabetes & Obesity

Obesity and type 2 diabetes are deeply intertwined conditions, and weight loss remains one of the most powerful therapeutic tools for managing the disease. However, sustaining weight loss long-term remains …

CONDITION: Metabolic and Endocrine

GENDER: Both males and females

AGE GROUP:?18?to 65 years

TRIAL STATUS:?Recruiting

ISAAC Trial – Invasive Strep A: Defining the Role of Antibiotic Prophylaxis in Contact Management

In the ISAAC trial, household contacts of iGAS (Invasive Group A Strep) cases will be invited to participate in the study. People who take part will be randomised to receive …

CONDITION: Infection

GENDER: All

AGE GROUP:?0?and above

TRIAL STATUS:?Recruiting

Weight Loss and Diabetes

Novatrials is seeking volunteers who are overweight and living with type 2 diabetes for a clinical study of a potential new treatment. The study medication is a once-weekly injection just …

CONDITION: Metabolic and Endocrine

GENDER: Both males and females

AGE GROUP:?18?and above

TRIAL STATUS:?Recruiting

Healthy Volunteer Clinical Study

Novatrials is seeking healthy volunteers to join a clinical study of a new potential treatment for kidney dysfunction. As part of this trial, you may receive the study drug or …

CONDITION: Other

GENDER: Both males and females

AGE GROUP:?18?to 65 years

TRIAL STATUS:?Recruiting

Healthy Volunteer Weight Loss Study

Healthy Volunteer Weight Loss Study | 3-Night In-Clinic Stay Novatrials is seeking healthy volunteers to join a clinical study of a potential new weight loss treatment. The purpose of this …

CONDITION: Other

GENDER: Both males and females

AGE GROUP:?18?to 60 years

TRIAL STATUS:?Recruiting

Post-Traumatic Stress Disorder (PTSD)

If you, or someone you know, are suffering from diagnosed PTSD, Novatrials is looking for volunteers to participate in a potential new treatment study. About the Study The study aims …

CONDITION: Mental Health

GENDER: Both males and females

AGE GROUP:?18?to 65 years

TRIAL STATUS:?Recruiting

Healthy Volunteers Needed for Idiopathic Pulmonary Fibrosis Study

Australian researchers are looking for healthy volunteers to test a potential new medical treatment for Idiopathic Pulmonary Fibrosis (IPF). IPF is a lung condition that causes progressive scarring of the …

CONDITION: Respiratory

GENDER: Both males and females

AGE GROUP:?26?to 65 years

TRIAL STATUS:?Recruiting

Abdominal Fat Reduction

Subcutaneous abdominal fat is the soft, pinchable layer located directly under the skin. High levels may be linked to health concerns like high blood pressure, elevated cholesterol, and elevated blood …

CONDITION: Other

GENDER: Both males and females

AGE GROUP:?18?and above

TRIAL STATUS:?Recruiting

Acne

Novatrials is seeking volunteers with acne to join a clinical study of a potential new treatment. You may be eligible to join the trial if you: are aged 18 to …

CONDITION: Skin

GENDER: Both males and females

AGE GROUP:?18?to 45 years

TRIAL STATUS:?Recruiting

Obesity and Health

Novatrials is recruiting volunteers who are living with obesity for a clinical study of a potential new treatment. The study medication is a once-weekly injection into the skin. It is …

CONDITION: Diet and Nutrition

GENDER: Both males and females

AGE GROUP:?18?and above

TRIAL STATUS:?Recruiting

HB-PTSD-001: Safety and Efficacy of HB-1 for PTSD: A Multi-center, Randomized, Double Blind, Placebo-Controlled Study

Safety and Efficacy of HB-1 for PTSD: A Multi-center, Randomized, Double Blind, Placebo-Controlled Study

CONDITION: Mental Health

GENDER:

AGE GROUP:?18?to 65 years

TRIAL STATUS:?Not yet recruiting

ONP-002-AU-001

This is a Phase IIa, randomized, double-blind, placebo-controlled pilot study to evaluate the safety, tolerability, pharmacokinetics (PK) and pharmacodynamics (PD) of ONP-002 in adults with mild traumatic brain injury (mTBI). …

CONDITION: Injuries and Accidents

GENDER: All

AGE GROUP:?18?to 75 years

TRIAL STATUS:?Recruiting

Immune-Related Diseases

Immune-mediated diseases are a broad category of conditions where the immune system functions abnormally and the immune response is inappropriate or excessive, resulting in harm to the body. Autoimmune diseases …

CONDITION: Inflammatory and Immune System

GENDER: Both males and females

AGE GROUP:?18?to 75 years

TRIAL STATUS:?Recruiting

Hyperlipidaemia

Do you have high cholesterol and high triglycerides? This common condition, called mixed hyperlipidaemia, means your blood contains too much of certain fats. When left untreated, it can increase your …

CONDITION: Cardiovascular

GENDER: Both males and females

AGE GROUP:?18?and above

TRIAL STATUS:?Recruiting

Skin Cancer

Novatrials is seeking volunteers with non-melanoma skin cancer to participate in a clinical study of a potential new treatment using a non-invasive device that emits a very gentle whole-body pulsed …

CONDITION: Cancer

GENDER: Both males and females

AGE GROUP:?40?to 75 years

TRIAL STATUS:?Recruiting

SUNRAY-01 – Metastatic Non-Small Cell Lung Cancer

About the Study This study is assessing whether a new targeted therapy (olomorasib) in combination with standard of care anti-cancer drugs (including immunotherapy and chemotherapy) is more effective than just …

CONDITION: Cancer

GENDER: Both males and females

AGE GROUP:?18?and above

TRIAL STATUS:?Recruiting

A Study of Imlunestrant Versus Standard Endocrine Therapy in Participants With Early Breast Cancer (EMBER-4)

About the Study The main purpose of this study is to test a potential new treatment for early breast cancer. The study will measure how well a new hormone therapy …

CONDITION: Cancer

GENDER: All

AGE GROUP:?18?and above

TRIAL STATUS:?Recruiting

MAXPIRe: Study to Evaluate Axatilimab in Participants With Idiopathic Pulmonary Fibrosis (IPF)

About the Maxpire IPF Study The Maxpire IPF Study is a clinical research study looking at a new investigational treatment for people living with Idiopathic Pulmonary Fibrosis (IPF). IPF is …

CONDITION: Respiratory

GENDER: All

AGE GROUP:?40?and above

TRIAL STATUS:?Active, not recruiting

HB-PD-002

About the Study This study is evaluating a potential new oral treatment for adults with panic disorder, a mental health condition marked by sudden and repeated episodes of intense fear, …

CONDITION: Mental Health

GENDER: All

AGE GROUP:?18?to 65 years

TRIAL STATUS:?Recruiting

Clinical Feasibility of the BinaxNOW™ COVID-19/​Flu A&B Combo in the Southern Hemisphere

The study is designed as a clinical feasibility, to investigate the positive and negative percent agreement (PPA and NPA) of the BinaxNOW™ COVID-19/Flu A&B Combo against a highly sensitive PCR …

CONDITION: Infection

GENDER: Both males and females

AGE GROUP:?2?and above

TRIAL STATUS:?Completed

A Multicenter, Open-Label, Randomized Phase 2a Study to Evaluate Safety and Efficacy of Ratutrelvir and Standard of Care in Non-hospitalized Symptomatic Adult Participants With Mild to Moderate COVID-19

This is an Early-stage Clinical Trial to Determine a Safe and Effective Dose for Ratutrelvir in Patients With Mild to Moderate COVID-19. It will also learn about the safety of …

CONDITION: Infection

GENDER: Both males and females

AGE GROUP:?18?and above

TRIAL STATUS:?Closed: follow-up complete

An Open-Label Biomarker Study of BHV-1300 in Graves’ Disease

The purpose of this study is to determine if BHV-1300 is a safe treatment in participants with Graves’ Disease and to explore its effect on disease-specific biomarkers.

CONDITION: Metabolic and Endocrine

GENDER: Both males and females

AGE GROUP:?18?to 65 years

TRIAL STATUS:?Recruiting

Gout

Novatrials is seeking volunteers with gout to join a clinical study of a potential new treatment for gout flares. You may be eligible to join this trial if you: have …

CONDITION: Inflammatory and Immune System

GENDER: Both males and females

AGE GROUP:?18?to 70 years

TRIAL STATUS:?Completed

Healthy Aging

Getting older affects every part of our health. As we age, our bodies gradually work less efficiently, making us more tired, less able to bounce back from illness or injury, …

CONDITION: Other

GENDER: Both males and females

AGE GROUP:?19?to 80 years

TRIAL STATUS:?Closed: follow-up continuing

Knee Osteoarthritis

Do you have moderate to severe knee pain from osteoarthritis? You may be eligible to join a clinical study of a potential new treatment. Why this trial matters Osteoarthritis can …

CONDITION: Musculoskeletal

GENDER: Both males and females

AGE GROUP:?18?to 85 years

TRIAL STATUS:?Closed: follow-up continuing

Cardiovascular Disease

Novatrials is enrolling volunteers with cardiovascular disease, and are living with obesity, in a clinical study of a potential new treatment that may help improve heart health outcomes. You may …

CONDITION: Cardiovascular

GENDER: Both males and females

AGE GROUP:?45?to 85 years

TRIAL STATUS:?Recruiting

Osteoarthritis Knee

Do you have moderate to severe knee pain from osteoarthritis? You may be eligible to join a clinical study of a potential new treatment. Why this trial matters Osteoarthritis can …

CONDITION: Musculoskeletal

GENDER: Both males and females

AGE GROUP:?18?to 85 years

TRIAL STATUS:?Closed: follow-up continuing

Prurigo Nodularis

Novatrials is now running a clinical trial of a potential treatment aimed at alleviating the symptoms of PN. If you are currently diagnosed with PN, would like to help in …

CONDITION: Skin

GENDER: Both males and females

AGE GROUP:?18?to 75 years

TRIAL STATUS:?Completed